ChartMill assigns a Buy % Consensus number of 83% to NDRA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-08 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-22 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-05-30 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-06-07 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-04-07 | HC Wainwright & Co. | Maintains | Buy |
7 analysts have analysed NDRA and the average price target is 38.76 USD. This implies a price increase of 662.99% is expected in the next year compared to the current price of 5.08.
The consensus rating for ENDRA LIFE SCIENCES INC (NDRA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.